Publikationen von Uwe Möginger

Möginger, U.; Grunewald, S.; Hennig, R.; Kuo, C.-W.; Schirmeister, F.; Voth, H.; Rapp, E.; Khoo, K.-H.; Seeberger, P. H.; Simon, J.-C. et al.; Kolarich, D.: Alterations of the human skin N- and O-glycome in basal- and squamous cell carcinoma. Frontiers in Oncology 8, 70 (2018)

Lohse, S.; Meyer, S.; Meulenbroek, L. A.P.M.; Jansen, J.H. M.; Nederend, M.; Kretschmer, A.; Klausz, K.; Möginger, U.; Derer, S.; Rösner, T. et al.; Kellner, C.; Schewe, D.; Sondermann, P.; Tiwari, S.; Kolarich, D.; Peipp, M.; Leusen, J. H.W.; Valerius, T.: An anti-EGFR IgA that displays improved pharmacokinetics and myeloid effector cell engagement in vivo. Cancer Research 76 (2), S. 403 - 417 (2016)

Möginger, U.; Resemann, A.; Martin, C. E.; Parameswarappa, S.; Govindan, S.; Wamhoff, E.-C.; Broecker, F.; Suckau, D.; Pereira, C. L.; Chakkumkal, A. et al.; Seeberger, P. H.; Kolarich, D.: Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Scientific Reports 6, 20488 (2016)

Marco-Ramell, A.; Miller, I.; Nöbauer, K.; Möginger, U.; Segales, J.; Razzazi-Fazeli, E.; Kolarich, D.; Bassols, A.: Proteomics on porcine haptoglobin and IgG/IgA show protein species distribution and glycosylation pattern to remain similar in PCV2-SD infection. Journal of Proteomics 101, S. 205 - 216 (2014)

Leymarie, N.; Griffin, P. J.; Jonscher, K.; Kolarich, D.; Orlando, R.; McComb, M.; Zaia, J.; Aguilan, J.; Alley, W. R.; Altmann, F. et al.; Ball, L. E.; Basumallick, L.; Bazemore-Walker, C. R.; Behnken, H.; Blank, M. A.; Brown, K. J.; Bunz, S.-C.; Cairo, C. W.; Cipollo, J. F.; Daneshfar, R.; Desaire, H.; Drake, R. R.; Go, E. P.; Goldman, R.; Gruber, C.; Halim, A.; Hathout, Y.; Hensbergen, P. J.; Horn, D. M.; Hurum, D.; Jabs, W.; Larson, G.; Ly, M.; Mann, B. F.; Marx, K.; Mechref, Y.; Meyer, B.; Moeginger, U.; Neusuess, C.; Nilsson, J.; Novotny, M. V.; Nyalwidhe, J. O.; Packer, N. H.; Pompach, P.; Reiz, B.; Resemann, A.; Rohrer, J. S.; Ruthenbeck, A.; Sanda, M.; Schulz, J. M.; Schweiger-Hufnagel, U.; Sihlbom, C.; Song, E.; Staples, G. O.; Suckau, D.; Tang, H.; Thaysen-Andersen, M.; Viner, R. I.; An, Y.; Valmuv, L.; Wada, Y.; Watson, M.; Windwarder, M.; Whittal, R.; Wuhrer, M.; Zhu, Y.; Zou, C.: Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Molecular and Cellular Proteomics 12 (10), S. 2935 - 2951 (2013)

Mosca, S.; Dannehl, C.; Möginger, U.; Brezesinski, G.; Hartmann, L.: β^(3R3)-peptides: design and synthesis of novel peptidomimetics and their self-assembling properties at the air-water interface. Organic & Biomolecular Chemistry 11 (33), S. 5399 - 5403 (2013)

Rösner, T.; Kretschmer, A.; Lohse, S.; Meyer, S.; Jansen, J. H. M.; Möginger, U.; Sondermann, P.; Kolarich, D.; Leusen, J. H. W.; Valerius, T.: Improvement of pharmacokinetics and myeloid effector cell engagement in vivo by Fc-engineering of IgA antibody against the epidermal growth factor receptor. In European Journal of Cancer, 69, 440, S. S144. Pergamon, Oxford, UK (2016)

Kretschmer, A.; Lohse, S.; Meyer, S.; Meulenbroek, L.A.P.M.; Jansen, J.H.M.; Möginger, U.; Sondermann, P.; Kolarich, D.; Leusen, J.H.W.; Valerius, T.: Glyco- and Fc engineering of IgA antibodies for cancer immunotherapy improved pharmacokinetics & myeloid effector cell engagement. In Oncology Research and Treatment, 39 (Suppl. 3), P276, S. 83 - 84. Jahrestagung der ­Deutschen, Österreichischen und ­Schweizerischen ­Gesellschaften für Hämatologie und ­Medizinische Onkologie, Leipzig, 14. Oktober 2016 - 18. Oktober 2016. Karger, Basel, Schweiz (2016)

Valerius, T.; Lohse, S.; Meyer, S.; Jansen, M. J.H.; Meulenbroek, L. A.P.; Nederend, M.; Möginger, U.; Kretschmer, A.; Klausz, K.; Derer, S. et al.; Sondermann, P.; Kolarich, D.; Peipp, M.; Leusen, J. H.W.; Gramatzki, M.: Pharmacokinetics and myeloid effector cell engagement of an engineered IgA antibody against the epidermal growth factor receptor. In Journal of Clinical Oncology, 33 supplement Aufl., abstract 3037. 2015 ASCO Annual Meeting. Grune & Stratton, New York, NY (2015)